News

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that the China National Medical Products Administration (NMPA) has approved and issued a Product license for the Company’s 23-Valent Pneumococcal Polysaccharide (“PPV”) Vaccine to prevent the infection...

Moncef Slaoui from Operation Warp Speed suggests that AstraZeneca and Johnson & Johnson COVID-19 doses will play a significant role in vaccinating everyone in the US. J&J candidate, being a one-shot vaccine will help in ramping up the...

02 NHS Workers have reportedly suffered from allergic reactions from the first jab of Pfizer-BioNtech COVID-19 vaccine in the UK. MHRA has issued an advisory asking people with an allergic history to refrain from vaccination. An air of apprehension...

The large amounts of dry ice needed to speed Covid-19 vaccine candidates to pandemic-weary populations will call for special attention from airlines and safety regulators. Dry ice, the solid form of carbon dioxide, is a critical part of plans to...

The ongoing synergy from the Covance consolidation is a major plus. However, a challenging volume environment for testing laboratories and softness in utilization are headwinds for LabCorp. Year to date, shares of LabCorp have improved 17.6% compared with the industry’s...

Bharat Biotech had applied to the Drugs Controller General of India seeking emergency use authorisation for its Covid-19 vaccine Covaxin. The Pune-based Serum Institute of India (SII) had applied to the central drug regulator for emergency use authorisation of...

Sheremetyevo International Airport was the launching point for an early batch of Russian Covid-19 vaccine Sputnik V. In total, 20 doses of the vaccine were transported from Moscow to Serbia where it will be used in clinical trials at...